These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 3863704)
1. Synergistic anticellular effect of a combination of beta-interferon and retinoic acid against U937 cells. Ho CK Cancer Res; 1985 Nov; 45(11 Pt 1):5348-51. PubMed ID: 3863704 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells. Kohlhepp EA; Condon ME; Hamburger AW Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521 [TBL] [Abstract][Full Text] [Related]
3. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928 [TBL] [Abstract][Full Text] [Related]
4. Interaction of retinoic acid and interferon-alpha in breast cancer cell lines. Widschwendter M; Daxenbichler G; Bachmair F; Müller E; Zeimet AG; Windbichler G; Uhl-Steidl M; Lang T; Marth C Anticancer Res; 1996; 16(1):369-74. PubMed ID: 8615638 [TBL] [Abstract][Full Text] [Related]
5. Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937. Taimi M; Defacque H; Commes T; Favero J; Caron E; Marti J; Dornand J Immunology; 1993 Jun; 79(2):229-35. PubMed ID: 8344702 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells. Hamburger AW; White CP; Siebenlist RE; Sedmak JJ; Grossberg SE Cancer Res; 1985 Nov; 45(11 Pt 1):5369-73. PubMed ID: 2996760 [TBL] [Abstract][Full Text] [Related]
7. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937. Gullberg U; Nilsson E; Einhorn S; Olsson I Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582 [TBL] [Abstract][Full Text] [Related]
8. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells. Tan YY; Epstein LB; Armstrong RD Cancer Res; 1989 Aug; 49(16):4431-4. PubMed ID: 2743331 [TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line. Buessow SC; Gillespie GY J Biol Response Mod; 1984 Dec; 3(6):653-62. PubMed ID: 6439829 [TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. Qi H; Ratnam M Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727 [TBL] [Abstract][Full Text] [Related]
12. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. Niitsu N; Ishii Y; Matsuda A; Honma Y Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Lingen MW; Polverini PJ; Bouck NP Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Lindner DJ; Borden EC; Kalvakolanu DV Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768 [TBL] [Abstract][Full Text] [Related]
15. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Olsson IL; Breitman TR; Gallo RC Cancer Res; 1982 Oct; 42(10):3928-33. PubMed ID: 6286101 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells. Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538 [TBL] [Abstract][Full Text] [Related]
17. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649 [TBL] [Abstract][Full Text] [Related]
18. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines. Dawson MJ; Trapani JA J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752 [TBL] [Abstract][Full Text] [Related]
19. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793 [TBL] [Abstract][Full Text] [Related]
20. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]